Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Flavoxate hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flavoxate 200mg tablets
0704020G0AAACAC
|
Flavoxate hydrochloride | Flavoxate hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3,390 |
|
Urispas 200 tablets
0704020G0BBABAC
|
Urispas | Flavoxate hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | 321 |
|
Flavoxate 100mg/5ml oral liquid
0704020G0AAAEAE
|
Flavoxate hydrochloride | Flavoxate hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Flavoxate 200mg/5ml oral suspension
0704020G0AAADAD
|
Flavoxate hydrochloride | Flavoxate hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Flavoxate 250mg/5ml oral liquid
0704020G0AAAFAF
|
Flavoxate hydrochloride | Flavoxate hydrochloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.